Product Name | NebuSelect™ Recombinant Human EPHA3, His-tag |
---|---|
Catalog Number | NBL-240872 |
Alias/Synonyms | EPHA3; EK4; HEK; ETK; ETK1; EPHA3; TYRO4; HEK4 |
Appearance | see COA |
Molecule Weight | Glu21-Gln541 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | P29320-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240872-100ug | 100ug | Inquire | Inquire | |
NBL-240872-1mg | 1mg | Inquire | Inquire | |
NBL-240872-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human EPHA3, His-tag
Catalog#:
NBL-240872
Description:
NebuSelect™ Recombinant Human EPHA3, His-tag(Cat#NBL-240872) is expressed in HEK293 with His tag at the C-Terminus.It contains Glu21-Gln541.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 59.9 kDa. Due to glycosylation, the protein migrates to 70-75 kDa based on Bis-Tris PAGE result.
Target Name:
EPHA3; EK4; HEK; ETK; ETK1; EPHA3; TYRO4; HEK4
Target Information:
Erythropoietin‑producing hepatocellular carcinoma cell surface type‑A receptor 3 (EPHA3) has been found to promote the proliferation and survival of prostate cancer (PCa) cell lines and prostate tumor development in nude mice. The interaction of AR and SP1 contributes to regulate EPHA3 expression, and the SP1 binding sites (‑295~‑261) in the EPHA3 core promoter region is crucial to the regulation of EPHA3 expression in response to androgen hormone stimuli.
Amino Acid Sequence:
Glu21-Gln541
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.